Partners Capital Investment Group, LLP Zai Lab LTD Transaction History

Partners Capital Investment Group, LLP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$27.77 - $64.4 $2.17 Million - $5.03 Million	-78,065 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$54.9 - $105.21 $1.99 Million - $3.81 Million	36,177 Added 86.37%	78,065 $4.91 Million
Q3 2021 Nov 15, 2021	BUY	$105.0 - $178.37 $324,030 - $550,449	3,086 Added 7.95%	41,888 $4.42 Million
Q1 2021 May 17, 2021	BUY	$126.27 - $191.71 $4.9 Million - $7.44 Million	38,802 New	38,802 $5.18 Million

121

46.7M

223K

588K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $2.72B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Partners Capital Investment Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Partners Capital Investment Group, LLP with notifications on news.